2021-02-24 // Bringing the VC approach to global health

Go to Article

2021-02-24 // Six years separated from a rabies vaccine scandal, China’s YishengBio grabs $130M to go big in infectious diseases, cancer

Go to Article

2021-02-18 // Pandemic Stokes Interest in Gates-Backed Public Health Fund

Go to Article

2021-02-18 // Adjuvant Capital Raises $300 Million Global-Health Venture Fund

Go to Article

2021-02-18 // VC style returns on ‘unsexy’ public health bets? Gates-backed Adjuvant Capital gathers $300M to mend a ‘failure of imagination’

Go to Article

2021-02-18 // Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases

Go to Article